Inhibition of Klenow DNA polymerase and poly(A)-specific ribonuclease by aminoglycosides

RNA

Volumn 8, Issue 11, 2002, Pages 1393-1400

  Ren, Yan Guo ^a   Martínez, Javier ^a   Kirsebom, Leif A ^a   Virtanen, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibiotics; DNA polymerase; Metalloenzymes; MRNA deadenylation

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DNA POLYMERASE; FRAMYCETIN; KANAMYCIN A; KANAMYCIN B; LIVIDOMYCIN; MESSENGER RNA; METAL ION; NEOMYCIN; PAROMOMYCIN; POLYADENYLIC ACID; RIBONUCLEASE; TOBRAMYCIN;

ARTICLE; CATALYSIS; COMPETITIVE INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; ELECTRICITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; ESCHERICHIA COLI; KINETICS; MOLECULAR CLONING; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BINDING SITES; DNA POLYMERASE I; DNA PRIMERS; ESCHERICHIA COLI; EXORIBONUCLEASES; FRAMYCETIN; HISTIDINE; HYDROGEN BONDING; HYDROXYL RADICAL; IRON; MAGNESIUM; MODELS, MOLECULAR; MOLECULAR MIMICRY; NEOMYCIN; NUCLEIC ACID CONFORMATION; POLYMERASE CHAIN REACTION; PROTEIN BINDING;

ESCHERICHIA COLI; MAMMALIA;

EID: 0036847881     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1355838202021015     Document Type: Article

References (50)

1. Åström J, Åström A, Virtanen A. 1991. In vitro deadenylation of mammalian mRNA by a HeLa cell 3′ exonuclease. EMBO J 10:3067-3071.
2. Åström J, Åström A, Virtanen A. 1992. Properties of a HeLa cell 3′ exonuclease specific for degrading poly(A) tails of mammalian mRNA. J Biol Chem 267:18154-18159.
3. Botto RE, Coxon B. 1983. Nitrogen-15 nuclear magnetic resonance spectroscopy of neomycin B and related aminoglycosides. J Am Chem Soc 105:1021-1028.
4. Brautigam CA, Steitz TA. 1998. Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes. Curr Opin Struc Biol 8:54-63.
5. Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103:1143-1154.
6. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 407:340-348.
7. Copeland PR, Wormington M. 2001. The mechanism and regulation of deadenylation: Identification and characterization of Xenopus PARN. RNA 7:875-886.
8. Davies J. 1994. New pathogens and old resistance genes. Microbiclogia 10:9-12.
9. Davies J, Wright GD. 1997. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5:234-240.
10. Earnshaw DJ, Gait MJ. 1998. Hairpin ribozyme cleavage catalyzed by aminoglycoside antibiotics and the polyamine spermine in the absence of metal ions. Nucleic Acids Res 26:5551-5561.
11. Eger BT, Benkovic SJ. 1992. Minimal kinetic mechanism for misincorporation by DNA polymerase I (Klenow fragment). Biochemistry 31:9227-9236.
12. Fourmy D, Recht MI, Blanchard SC, Puglisi JD. 1996. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371.
13. Fourmy D, Yoshizawa S, Puglisi JD. 1998. Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J Mol Biol 277:333-345.
14. Hansen S, Hansen LK, Hough E. 1993. The crystal structure of trisinhibited phospholipase C from Bacillus cereus at 1.9 A resolution. The nature of the metal ion in site 2. J Mol Biol 231:870-876.
15. Hermann T, Westhof E. 1998. Aminoglycoside binding to the hammerhead ribozyme: A general model for the interaction of cationic antibiotics with RNA. J Mol Biol 276:903-912.
16. Hoch I, Berens C, Westhof E, Schroeder R. 1998. Antibiotic inhibition of RNA catalysis: Neomycin B binds to the catalytic core of the td group I intron displacing essential metal ions. J Mol Biol 282:557-569.
17. Joyce CM, Steitz TA. 1995. Polymerase structures and function: Variations on a theme? J Bacteriol 177:6321-6329.
18. Korner CG, Wahle E. 1997. Poly(A) tail shortening by a mammalian poly (A)-specific 3′-exoribonuclease. J Biol Chem 272:10448-10456.
19. Korner CG, Wormington M, Muckenthaler M, Schneider S, Dehlin E, Wahle E. 1998. The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J 17:5427-5437.
20. Lazarus LH, Kitron N. 1973. Neomycin inhibition of DNA polymerase. Biochem Pharmacol 22:3115-3117.
21. MacBeath G, Schreiber SL. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289:1760-1763.
22. Martinez J, Ren YG, Thuresson AC, Hellman U, Astrom J, Virtanen A. 2000. A 54-kDa fragment of the poly (A)-specific ribonuclease is an oligomeric, processive, and cap-interacting poly (A)-specific 3′ exonuclease. J Biol Chem 275:24222-24230.
23. McDonald LJ, Mamrack MD. 1995. Phosphoinositide hydrolysis by phospholipase C modulated by multivalent cations La(3+), Al(3+), neomycin, polyamines, and melittin. J Lipid Mediat Cell Signal 11:81-91.
24. Mei HY, Mack DP, Galan AA, Halim NS, Heldsinger A, Loo JA, Moreland DW, Sannes-Lowery KA, Sharmeen L, Truong HN, Czarnik AW. 1997. Discovery of selective, small-molecule inhibitors of RNA complexes-I. The Tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorg Med Chem 5:1173-1184.
25. Mian IS. 1997. Comparative sequence analysis of ribonucleases HII, III, II PH and D. Nucleic Acids Res 25:3187-3195.
26. Mikkelsen NE, Brännvall M, Virtanen A, Kirsebom L. 1999. Inhibition of RNase P cleavage by aminoglycosides. Proc Natl Acad Sci USA 96:6155-6160.
27. Mikkelsen NE, Johansson K, Virtanen A, Kirsebom LA. 2001. Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complex. Nat Struct Biol 8:510-514.
28. Moazed D, Noller HF. 1987. Interaction of antibiotics with functional sites in 16S ribosomal RNA. Nature 327:389-394.
29. Ren YG, Martinez J, Virtanen A. 2002. Identification of the active site of poly(A)-specific ribonuclease by site-directed mutagenesis and Fe (2+)-mediated cleavage. J Biol Chem 277:5982-5987.
30. Rogers J, Chang AH, von Ahsen U, Schroeder R, Davies J. 1996. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J Mol Biol 259:916-925.
31. Schacht J. 1999. Antioxidant therapy attenuates aminoglycoside-induced hearing loss. Ann NY Acad Sci 884:125-130.
32. Stage TK, Hertel KJ, Uhlenbeck OC. 1995. Inhibition of the hammerhead ribozyme by neomycin. RNA 1:95-101.
33. Steitz TA. 1999. DNA polymerases: Structural diversity and common mechanisms. J Biol Chem 274:17395-17398.
34. Steitz TA, Steitz JA. 1993. A general two-site-metal-ion mechanism for catalytic RNA. Proc Natl Acad Sci USA 90:6498-6502.
35. Szilagyi L, Pusztahelyi ZS, Jakab S, Kovacs I. 1993. Microscopic protonation constants in tobramycin. An NMR and pH study with the aid of partially N-acetylated derivatives. Carbohydr Res 247:99-109.
36. Tekos A, Tsagla A, Stathopoulos C, Drainas D. 2000. Inhibition of eukaryotic ribonuclease P activity by aminoglycosides: Kinetic studies. FEBS Lett 485:71-75.
37. Teplova M, Wallace ST, Tereshko V, Minasov G, Symons AM, Cook PD, Manoharan M, Egli M. 1999. Structural origins of the exonuclease resistance of a zwitterionic RNA. Proc Natl Acad Sci USA 96:14240-14245.
38. Tor Y, Hermann T, Westhof E. 1998. Deciphering RNA recognition: Aminoglycoside binding to the hammerhead ribozyme. Chem Biol 5:277-283.
39. Vicens Q, Westhof E. 2001. Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure (Camb) 9:647-658.
40. von Ahsen U, Davies J, Schroeder R. 1991. Antibiotic inhibition of group I ribozyme function. Nature 353:368-370.
41. von Ahsen U, Davies J, Schroeder R. 1992. Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. J Mol Biol 226:935-941.
42. Walter F, Putz J, Giege R, Westhof E. 2002. Binding of tobramycin leads to conformational changes in yeast tRNA(Asp) and inhibition of aminoacylation. EMBO J 21:760-768.
43. Walter F, Vicens Q, Westhof E. 1999. Aminoglycoside-RNA interactions. Curr Opin Chem Biol 3:694-704.
44. Wang H, Tor Y. 1997. Electrostatic interactions in RNA aminoglycosides binding. J Am Chem Soc 119:8734-8735.
45. Werstuck G, Zapp ML, Green MR. 1996. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition. Chem Biol 3:129-137.
46. Woegerbauer M, Burgmann H, Davies J, Graninger W. 2000. DNase I induced DNA degradation is inhibited by neomycin. J Antibiot (Tokyo) 53:276-285.
47. Woodcock J, Moazed D, Cannon M, Davies J, Noller HF. 1991. Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. EMBO J 10:3099-3103.
48. Yoshizawa S, Fourmy D, Puglisi JD. 1998. Structural origins of gentamicin antibiotic action. EMBO J 17:6437-6448.
49. Zapp ML, Stern S, Green MR. 1993. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74:969-978.
50. Zembower TR, Noskin GA, Postelnick MJ, Nguyen C, Peterson LR. 1998. The utility of aminoglycosides in an era of emerging drug resistance. Int J Antimicrob Agents 10:95-105.